Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Chiome Bioscience Inc. ( (JP:4583) ) just unveiled an announcement.
Chiome Bioscience Inc. reported its financial results for the nine months ending September 30, 2025, showing a decrease in net sales and continued losses. The company has not revised its financial forecasts, indicating ongoing challenges in its drug discovery and development business, while maintaining a focus on its drug discovery support services.
More about Chiome Bioscience Inc.
Chiome Bioscience Inc. operates in the biotechnology industry, focusing on drug discovery and development. The company is listed on the Tokyo Stock Exchange and engages in drug discovery support services.
Average Trading Volume: 567,676
Technical Sentiment Signal: Sell
Current Market Cap: Yen9.05B
See more data about 4583 stock on TipRanks’ Stock Analysis page.